In addition, gene expression profiling in metastatic prostate cancer and in TNBC showed FOXM1 to be one of the top differentially expressed genes, with the potential to regulate many of the signaling pathways that control the hallmarks of cancer [11,26]. This evidence concerns the gene FOXM1 and cancer.